Alnylam Pharmaceuticals Inc logo

Alnylam Pharmaceuticals Inc

2
NAS:ALNY (USA)   Ordinary Shares
$ 153.57 -0.825 (-0.53%) 09:45 AM EST
At Loss
Market Cap:
$ 19.34B
Enterprise V:
$ 18.30B
Volume:
9.30K
Avg Vol (2M):
1.01M
Also Trade In:
Volume:
9.30K
At Loss
Avg Vol (2M):
1.01M

Alnylam Pharmaceuticals Inc Stock Institutional Ownership and Insider Ownership -

125.95
(Mil)
Shares Outstanding
91.45%
115.18 (Mil)
Institutional Ownership
0.36%
0.46 (Mil)
Insider Ownership 1
75.77%
95.4321 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Alnylam Pharmaceuticals Inc. Peter Lynch prefers to buy companies with low institutional ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Insider ownership (%)

This is the historical insider ownership of Alnylam Pharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.
1. Please note that our data vendor collects insider data for officers and directors from Forms 3,4,5 and amendments where they only capture direct ownership data, not indirect ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Top Direct Holders

Top Fund Holders